Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€97.41

€97.41

-1.080%
-1.05
-1.080%
-
 
22:25 / Tradegate WKN: 852684 / Symbol: TD / Name: TD / Stock / Banking Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for TD

sharewise wants to provide you with the best news and tools for TD, so we directly link to the best financial data sources.

News

Core Scientific Targets AI Data Center Deals as Build Costs Climb
Core Scientific Targets AI Data Center Deals as Build Costs Climb

Key Points

EQB Q2 Earnings Call Highlights
EQB Q2 Earnings Call Highlights

Key Points

Toronto Dominion Bank Q2 Earnings Call Highlights
Toronto Dominion Bank Q2 Earnings Call Highlights

Key Points

Aura Biosciences Gears Up for Bel-Sar Filing as Pivotal Eye Cancer Trial Advances
Aura Biosciences Gears Up for Bel-Sar Filing as Pivotal Eye Cancer Trial Advances

Key Points

Amazon's Alexa for Shopping Strengthens an Already Strong Bull Case
Amazon's Alexa for Shopping Strengthens an Already Strong Bull Case

Key Points

Astera Labs Targets $10B AI Connectivity Opportunity as Scorpio X-Series Ramps
Astera Labs Targets $10B AI Connectivity Opportunity as Scorpio X-Series Ramps

Key Points

IDEAYA Biosciences Spotlights Darovasertib Win, FDA Review Path at Oncology Summit
IDEAYA Biosciences Spotlights Darovasertib Win, FDA Review Path at Oncology Summit

Key Points

Doman Building Materials Group Q1 Earnings Call Highlights
Doman Building Materials Group Q1 Earnings Call Highlights

Doman Building Materials Group (TSE:DBM) reported lower first-quarter revenue as weaker pricing across key construction material categories offset steady shipment activity, while margins improved

Constellation Software Q1 Earnings Call Highlights
Constellation Software Q1 Earnings Call Highlights

Constellation Software (TSE:CSU) executives used the company’s first-quarter conference call to discuss acquisition activity, margin pressures, artificial intelligence and the company’s approach to

CCL Industries Q1 Earnings Call Highlights
CCL Industries Q1 Earnings Call Highlights

CCL Industries (TSE:CCL.A) reported modest first-quarter sales growth and nearly flat operating income, while management said demand remained generally stable despite inflation pressures and

Radiant Logistics Q3 Earnings Call Highlights
Radiant Logistics Q3 Earnings Call Highlights

Radiant Logistics (NYSEAMERICAN:RLGT) reported higher net income for its fiscal third quarter ended March 31, 2026, while adjusted earnings measures declined from the prior-year period, as

OR Royalties Q1 Earnings Call Highlights
OR Royalties Q1 Earnings Call Highlights

OR Royalties (NYSE:OR) reported a record first quarter of 2026, with President and CEO Jason Attew saying the company is “off to an impressive

MDxHealth Q1 Earnings Call Highlights
MDxHealth Q1 Earnings Call Highlights

MDxHealth (NASDAQ:MDXH) reported first-quarter 2026 revenue of $27.4 million while announcing a strategic exit from its Resolve UTI testing business and the planned closure of its Plano, Texas

Eos Energy Enterprises Q1 Earnings Call Highlights
Eos Energy Enterprises Q1 Earnings Call Highlights

Eos Energy Enterprises (NASDAQ:EOSE) reported a sharp year-over-year increase in first-quarter revenue and outlined a new project financing

Humacyte Q1 Earnings Call Highlights
Humacyte Q1 Earnings Call Highlights

Humacyte (NASDAQ:HUMA) reported first-quarter 2026 Symvess sales of $0.5 million and outlined a series of commercial, clinical and cost-reduction initiatives aimed at accelerating adoption of its

Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?
Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?

Rocket Lab (NASDAQ: RKLB) just had one of the most extraordinary weeks ever in its history as a public company. The stock closed at a new all-time high of $117.35 on Tuesday, having surged over

Uniti Group Q1 Earnings Call Highlights
Uniti Group Q1 Earnings Call Highlights

Uniti Group (NASDAQ:UNIT) executives said the company started 2026 with stronger fiber growth, record Kinetic customer activity and continued demand from hyperscale customers tied to artificial

Sharplink Gaming Q1 Earnings Call Highlights
Sharplink Gaming Q1 Earnings Call Highlights

Sharplink Gaming (NASDAQ:SBET) reported a sharp increase in first-quarter revenue as management emphasized its Ethereum treasury strategy, while the

Ginkgo Bioworks Q1 Earnings Call Highlights
Ginkgo Bioworks Q1 Earnings Call Highlights

Ginkgo Bioworks (NYSE:DNA) said it is sharpening its 2026 focus on autonomous laboratories after completing the divestiture of its biosecurity business and reporting lower year-over-year cash burn

Outset Medical Q1 Earnings Call Highlights
Outset Medical Q1 Earnings Call Highlights

Outset Medical (NASDAQ:OM) reported first-quarter 2026 revenue of $27.9 million, as management pointed to “consistent execution” in console

5 Stocks Leading the Market's Rebound: The AI Connectivity Trade
5 Stocks Leading the Market's Rebound: The AI Connectivity Trade

While the broader market has spent much of 2026 fighting through a correction and uncertainty, a handful of stocks have not only held their ground but delivered extraordinary year-to-date (YTD)

Blue Owl’s Risk/Reward Profile Is Almost Too Good to Be True
Blue Owl’s Risk/Reward Profile Is Almost Too Good to Be True

Blue Owl Capital Inc. (NYSE: OWL), an alternative investment asset management group, has been making headlines for all the wrong reasons lately.

Shares are currently trading around $9, down

Rocket Lab’s Neutron Hiccup Sparked a Sell-Off—Overreaction or Omen?
Rocket Lab’s Neutron Hiccup Sparked a Sell-Off—Overreaction or Omen?

Shares of Rocket Lab Corporation (NASDAQ: RKLB), one of the fastest-growing names in the aerospace and defense space, have come under pressure recently. The stock is down nearly 10% for the month

GE Vernova’s Q4 Was Strong—But the Backlog Number Matters More
GE Vernova’s Q4 Was Strong—But the Backlog Number Matters More

Power and electrification company GE Vernova (NYSE: GEV) was a standout performer in 2025, delivering a total return of approximately 99%.

Shares are already up by almost 10% in 2026, buoyed by